ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

LIXT Lixte Biotechnology Holdings Inc

2.82
-0.0621 (-2.15%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Lixte Biotechnology Holdings Inc LIXT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0621 -2.15% 2.82 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.00 2.8735 3.002 2.89 2.8821
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202414:25APSMixed Shelf Filing Gives Micro Cap Delayed Boost
27/3/202414:35APSBiotech Steals The Show Following Pre-Clinical Data..
27/3/202407:30GLOBENEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD..
21/3/202407:30GLOBELIXTE Provides Update on Progress with LB-100 as a PP2A..
27/2/202415:59EDGAR2Form 8-K - Current report
27/2/202407:30GLOBEProfessor René Bernards to Present New Pre-Clinical Data on..
26/2/202409:48EDGAR2Form 8-K - Current report
26/2/202407:30GLOBELIXTE Biotechnology Enters into Exclusive Immune Oncology..
29/1/202407:30GLOBEFirst Patient Dosed with LIXTE’s LB-100 and GSK’s..
28/11/202316:21EDGAR2Form 8-K - Current report
13/11/202313:28EDGAR2Form 8-K - Current report
13/11/202307:30GLOBELIXTE Biotechnology Provides Update on Clinical Progress and..
09/11/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/10/202316:27EDGAR2Form 8-K - Current report
16/10/202313:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202307:30GLOBELIXTE, Netherlands Cancer Institute, and Oncode Institute to..
10/10/202314:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/10/202314:47EDGAR2Form DEF 14A - Other definitive proxy statements
09/10/202307:30GLOBELIXTE Biotechnology Holdings Announces the Passing of its..
05/10/202319:39EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
05/10/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
27/9/202305:15EDGAR2Form 8-K - Current report
27/9/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202307:30GLOBELIXTE Appoints Bas van der Baan as President and Chief..
20/9/202310:20EDGAR2Form 8-K - Current report
20/9/202307:30GLOBELIXTE Biotechnology Announces a Supported Collaborative..
11/8/202315:20EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/7/202315:05EDGAR2Form 8-K - Current report
20/7/202315:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/7/202315:05GLOBELIXTE Biotechnology Announces Closing of $3.5 Million..
20/7/202310:45EDGAR2Form 8-K - Current report
18/7/202307:00GLOBELIXTE Biotechnology Announces Pricing of $3.5 Million..
17/7/202307:30GLOBEPreclinical Results of LIXTE Biotechnology’s Collaboration..
07/7/202313:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202309:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202309:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202309:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/6/202307:30GLOBELIXTE Biotechnology Holdings, Inc. Regains Compliance with..
07/6/202307:30GLOBELIXTE Biotechnology and the Spanish Sarcoma Group Enroll..
02/6/202311:30GLOBELIXTE Biotechnology Holdings, Inc. Announces 1-for-10..
30/5/202307:30GLOBERecently Published Independent Research Reveals New..

Su Consulta Reciente

Delayed Upgrade Clock